Confo Therapeutics’ unparalleled technology stabilizes functional conformations of GPCRs (G protein-coupled receptors) to uncover a wide range of previously inaccessible GPCRs as drug targets.
This technology platform combined with the pharmacologic and biologic insight it provides, allows Confo to build a multi-indication pipeline of drug candidates with the potential to transform therapeutic outcomes for patients with severe illnesses lacking disease-modifying treatments.
Confo Therapeutics was spun out of Vrije Universiteit Brussel (VUB) and VIB in 2015. Supported by international life-science focused investors and led by an experienced team of entrepreneurial professionals and scientists from successful biopharmaceutical companies, Confo Therapeutics benefits from the rich scientific and innovative ecosystem in Belgium.
For more information: www.confotherapeutics.com
Company Details
- Employees
- 77
- Founded
- -
- Address
- Rijvisschestraat 120, Zwijnaarde,9052,belgium
- in****@****ics.com
- Industry
- Biotechnology
- Website
- http://www.confotherapeutics.com
- HQ
- Zwijnaarde
Confo Therapeutics Questions
Confo Therapeutics's website is http://www.confotherapeutics.com
Confo Therapeutics's LinkedIn profile is https://be.linkedin.com/company/confo-therapeutics
Confo Therapeutics has
77 employees.
View email and phone details for 77
employees at Confo Therapeutics.
Confo Therapeutics's industry is
Biotechnology
Confo Therapeutics's support email address is info@confotherapeutics.com
Confo Therapeutics's categories are Biotechnology
Confo Therapeutics's founding year is 2015
